Home
|
Search
|
Register
|
Sign in
Funding Needed
Looking To Invest
Business Ideas
Need an Expert
Resources
All About Angel Investors
All About Venture Capitalists
Business Funding Resources
Small Business Funding
Startup Capital Needs
Business Plans & Proposals
Entrepreneur - New Business
Angel Investors needed for Biomarkers as a Service (BaaS) enterprise
Posted by:
Sandy Shaw
on 3/12/2011 5:31:18 PM
Close
Please specify a reason for reporting this post.
Login
to rate
Thanks for rating!
Funding Needed
:
$250k - $500k
Category:
Biotechnology
Website :
Please
login
to view.
Location :
San Francisco,
USA
Viewed :
1317
times
Favorited :
1
times
Please
Login
to share this post.
Share This Post
To:
(Separate emails by commas)
Message:
(Message is optional)
Description:
We have developed a new approach to genomics that generates one number to define a patient’s condition across the entire genetic level, a "thermometer" for genetic health. This method produces results that can predict response to drug treatment months in advance of clinical assessments, improve the efficiency of the drug pipeline, and provide better ways to measure the true health of patients.
Only 8% of drug candidates currently make it through clinical trials to FDA approval, often at the cost of hundreds of millions of dollars. To improve on this process, a small but increasing number of companies now offer genetic biomarker services to pharmaceutical, biotech, and contract research organizations (CROs). The use of biomarkers in the pharmaceutical pipeline has now become an important part of the $20 billion biomarker industry. Within this burgeoning market, our company offers the capability of improved prediction, a wider breadth of biomarkers, and the ability to quickly develop biomarkers customized to the clients needs. Our company is the first company that truly offers Biomarkers as a Service (BaaS).
We are seeking $375K to build out our core staff and port our current processing platform to the cloud (Amazon EC2). We expect rapid growth in revenue as our services are utilized in the growing surrogate biomarker industry, leading to a high multiple acquisition in the 2-5 years time frame. Executive Summary and case studies available upon request.
Digg It
Stumble It
Deli.icio.us
Respond
You must be a member to respond to this post. If you are a member , please login to respond.